AI as MedTech's growth engine: From point solutions to platforms
27 Aug 2026
AI is transitioning from a point solution in healthcare to the operating layer for discovery, delivery and scale. Rapid advances in AI computing, a fast-growing base of healthcare data and the steady digitisation of clinical workflows are creating the conditions for AI to become part of everyday healthcare.
Across the value chain, AI is being embedded at every stage. In pharma and life sciences, it supports drug discovery, clinical trials, manufacturing optimisation and pharmacovigilance. In MedTech, it spans product design, diagnostics and imaging, and remote monitoring. Healthcare providers are applying it to administrative automation, clinical decision support, follow-up and readmission-risk prediction. Across all three, the outcomes are consistent: faster innovation, better clinical accuracy, higher workforce productivity, and continuous monitoring and safer care.
Exhibit 1: Healthcare ecosystem embracing AI
The global AI in healthcare market is projected to grow from about US$ 50B in 2026 to about US$ 505B by 2033, a CAGR of 39%. The growth is driven by structural pressures on healthcare systems. A rising chronic disease burden is increasing the need for early diagnosis and continuous management, while shortages of specialist capacity are driving demand for productivity and clinical decision support.
AI-enabled medical devices account for about half of this market, growing from US$ 26B in 2026 to a projected US$ 255B by 2033, broadly in line with the wider market. The opportunity, however, extends well beyond devices, AI is becoming embedded across the healthcare ecosystem.
Exhibit 2: Global AI in healthcare market
Transitioning from passive to active platforms
AI turns the medical device from a passive data generator into an active decision-support platform. In conventional pathways, devices produce raw data that only specialists can interpret, which means slow diagnosis, heavy workloads, variability across readers and largely reactive care. Embedding AI at the point of data capture automates the first read through real-time analysis, automatic detection, case prioritization and risk prediction, so clinicians validate AI-driven insights instead of decoding raw signals.
The gains follow directly:
- Faster diagnosis and earlier intervention: interpretation no longer sets the pace, and care shifts from reactive to proactive.
- Higher productivity and better consistency: specialists validate rather than decade, and automated detection narrows variability across readers.
- Greater access: diagnosis reaches more patients.
This compresses the journey from scan to decision, enabling earlier intervention and more consistent outcomes while keeping the clinician firmly in the loop. .
Exhibit 3: AI in MedTech - passive to active platforms
The opportunity is bigger than AI adoption
The potential of AI-driven MedTech extends far beyond simply adopting new technologies. It lies in building robust ecosystems capable of creating, clinically validating, adopting, and scaling intelligent medical solutions across global healthcare systems and diverse patient demographics.
The opportunity is not just to make medical devices smarter. It is to make healthcare system more accessible, productive and scalable.
For a deeper look at the opportunity, adoption barriers and actions required to scale AI-enabled MedTech in India, read the full knowledge paper, AI in MedTech: Revolutionizing Healthcare Through Artificial Intelligence.